The
coating of gold nanorods with a silica shell (AuNR@SiO2) is an effective way to extend their use in a wide variety
of biomedical applications including biosensing, drug delivery and
photothermal therapy. A silica shell offers numerous advantages as
it provides more stability, frees the surface from toxic cetyltrimethylammonium
bromide (CTAB), and preserves the rod shape under photothermal conditions.
This shell needs to be very thin for applications such as plasmonic
biosensing, while a thicker and porous shell is suited for drug encapsulation
and further controlled release. We introduce herein a strategy to
perform silica coating based on dissociation of tetraethylorthosilicate
(TEOS) hydrolysis and condensation reactions. This dissociation is
achieved by a pH modulation of the reaction medium, and, depending
on selected pH conditions, AuNR@SiO2 with a thick silica
shell having an organized mesoporosity aligned either parallel (AuNR@//m-SiO2) or perpendicular (AuNR@⊥m-SiO2) to the
AuNR surface was generated. Moreover, when mercaptopropyltrimethoxysilane
(MPTMS) was used as a surface primer prior to TEOS condensation, ultrathin
and homogeneous silica shells (AuNR@t-SiO2) of controllable
thickness in the range 2–6 nm were produced. While formation,
at high TEOS concentration, of core-free silica nanoparticles is evidenced
by TEM analysis before the purification procedure, their total elimination
during the purification step was achieved by addition of a suitable
amount of CTAB to ensure the colloidal stability of the core-free
and core–shell nanoparticles. Complete elimination of CTAB
from AuNR@SiO2 was demonstrated by XPS, Raman, and ζ-potential
measurements. Finally, the efficiency of AuNR@t-SiO2 in
label-free plasmonic biosensing of a model target was demonstrated
and their refractive index sensitivity factor was improved by 30%
compared to CTAB-capped AuNRs